ストックスクリーナーアプリを入手
22.04
2.27%
0.49
アフターアワーズ：
21.96
-0.08
-0.36%
前日終値:
$21.55
開ける：
$21.47
24時間の取引高:
10.26M
Relative Volume:
1.40
時価総額：
$11.38B
収益：
$11.32B
当期純損益:
$-981.00M
株価収益率:
-11.28
EPS:
-1.9532
ネットキャッシュフロー:
$714.00M
1週間 パフォーマンス:
+10.81%
1か月 パフォーマンス:
+13.73%
6か月 パフォーマンス:
+13.73%
1年 パフォーマンス:
-27.74%
1日の値動き範囲:
$21.43
$22.18
1週間の範囲:
$19.42
$22.18
52週間の値動き範囲:
$15.73
$31.75
Baxter International Inc Stock (BAX) Company Profile
名前
Baxter International Inc
セクター
電話
(224) 948-2000
住所
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
22.04 | 11.38B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
404.70 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.92 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.80 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.87 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
200.29 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-31 | ダウングレード | Argus | Buy → Hold |
| 2025-08-04 | ダウングレード | Stifel | Buy → Hold |
| 2025-08-01 | ダウングレード | Goldman | Buy → Neutral |
| 2025-02-26 | 再開されました | Goldman | Buy |
| 2025-02-24 | アップグレード | Argus | Hold → Buy |
| 2025-02-20 | 再開されました | Barclays | Overweight |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-12-15 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-06-24 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Goldman | Neutral → Sell |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-18 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-18 | 繰り返されました | Raymond James | Outperform |
| 2022-02-18 | 繰り返されました | Stifel | Buy |
| 2022-02-18 | 繰り返されました | UBS | Neutral |
| 2022-02-18 | 繰り返されました | Wells Fargo | Overweight |
| 2022-02-11 | 開始されました | Goldman | Neutral |
| 2022-01-07 | 再開されました | Citigroup | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-09-03 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | ダウングレード | UBS | Buy → Neutral |
| 2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
| 2020-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2020-09-04 | ダウングレード | Argus | Buy → Hold |
| 2020-06-24 | 開始されました | Oppenheimer | Outperform |
| 2020-03-19 | アップグレード | Stifel | Hold → Buy |
| 2020-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-02 | アップグレード | Citigroup | Neutral → Buy |
| 2019-01-02 | アップグレード | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | アップグレード | Argus | Hold → Buy |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-05-17 | 再開されました | Piper Jaffray | Overweight |
| 2018-02-06 | 繰り返されました | Citigroup | Neutral |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
すべてを表示
Baxter International Inc (BAX) 最新ニュース
Baxter International edges higher with sector peers, shares trade on NYSE - Ad-hoc-news.de
Baxter's unit Synovis MCA to lead global rollout of the SHIYA platform - MSN
The PrisMax System from Baxter International Inc.flexible CRRT for fragile ICU patients - Ad-hoc-news.de
Is Baxter International stock underperforming the S&P 500? - MSN
Baxter International focuses on long-term portfolio shift, shares in S&P 500 healthcare spotlight - Ad-hoc-news.de
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Enterprise value to EBIT forward of Baxter International Inc. – NYSE:BAX - TradingView
Baxter International weekly move, shares lag key healthcare peers - Ad-hoc-news.de
Price to sales forward of Baxter International Inc. – NYSE:BAX - TradingView
Price to earnings forward of Baxter International Inc. – NYSE:BAX - TradingView
Enterprise value to revenue forward of Baxter International Inc. – NYSE:BAX - TradingView
Baxter International Inc. Actuals & Estimates (NYSE:BAX) - TradingView
Baxter International consensus picture builds, shares trade below recent highs - Ad-hoc-news.de
Enterprise value to EBIT forward of Baxter International Inc. – HAM:BTL - TradingView
Biotin Vitamin Supplement Market Growth Outlook to 2035: Fermentation Demand and Supply DynamicsNews and Statistics - IndexBox
Why Baxter International Inc (BAX) May Struggle to Outperform: A Look at Future Challenges - GuruFocus
'Family Ties' star Michael Gross celebrates TV wife Meredith Baxter as they turn 79 - Toronto Sun
CardioMech Shareholders Appoint Ramin Mousavi as Chairman of the Board | Newswise - Newswise
Albireo Energy in Edison appoints Baxter as CEO - ROI-NJ
Baxter International focuses on dialysis and hospital portfolio, shares on NYSE under analyst watch - Ad-hoc-news.de
US FDA Turns to Indian Drugmakers as Critical Cancer Medicine Shortage Deepens - slguardian.org
Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact - StreetInsider
Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Baxter International Inc. (BAX) Stock Analysis: Navigating Healthcare Challenges with a Potential 8.3% Upside - DirectorsTalk Interviews
Baxter International StockWeekly outlook with earnings ahead - Ad-hoc-news.de
Postmedia's Vaughn Palmer, Bruce MacKinnon share 2026 Michener-Baxter Award honours - National Post
Famous birthdays for June 21: Prince William, Meredith Baxter - upi.com
Baxter International (BAX) Stock Could Be 7.7% Undervalued After MediThinQ Distribution Deal - Sahm
Quietly crucial on the ward, Baxter’s Sigma Spectrum infusion pump in everyday use - AD HOC NEWS
Why Baxter’s Spectrum IQ smart pump is drawing fresh attention in hospitals - AD HOC NEWS
Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform - Yahoo Finance
Business News - LatestLY
Quietly precise, Baxter Spectrum IQ aims to make IV pumps less stressful - AD HOC NEWS
Baxter International Inc (BAX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Baxter International Inc (BAX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Smart safety touches, Baxter Spectrum IQ pump aims for quieter hospital days - AD HOC NEWS
symbol__ Stock Quote Price and Forecast - CNN
MediThinQ partners with Baxter unit to distribute 3D platform - Investing.com
Baxter International Unit Signs Distribution Deal for Surgical Visualization Platform - Moomoo
MediThinQ partners with Baxter unit to distribute 3D platform By Investing.com - Investing.com India
Baxter International Inc. stock underperforms Wednesday when compared to competitors - MSN
Investors who lost money with shares of ADMA Biologics, Inc. - openPR.com
Baxter International Inc (BAX) Stock Down 5.2% -- Now Undervalued? GF Score: 60/100 - GuruFocus
Baxter International Inc (BAX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Baxter International Inc (BAX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Baxter International Inc (BAX) Institutional Confidence - TradingKey
Baxter International Inc (BAX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Baxter International Inc (BAX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Baxter International Inc (BAX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is Baxter International Stock Underperforming the S&P 500? - Barchart.com
Baxter’s Post-Divestiture Profit Focus Might Change The Case For Investing In Baxter International (BAX) - simplywall.st
Baxter International Inc (BAX) 財務データ
収益
当期純利益
現金流量
EPS
1.55%
大文字化:
|
ボリューム (24 時間):